Yi Ba
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in ⓘ
-
- Extracellular vesicles in disease 5
- Peroxisome Proliferator-Activated Receptors 2
- RNA Interference and Gene Delivery 2
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Haiyang Zhang (8 shared papers)Ting Deng (4 shared papers)Xinyi Wang (4 shared papers)Guoguang Ying (4 shared papers)Ralph A. Reisfeld (1 shared paper)Noriko Mizutani (1 shared paper)Yunping Luo (1 shared paper)Rong Xiang (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Oncology (1 paper)Investigational New Drugs (1 paper)Cell Research (1 paper)Cold Spring Harbor Perspectives in Medicine (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Yi Ba
20 papers receiving 656 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 322
- Molecular Biology 503
- Immunology 119
- Geriatrics and Gerontology 18
- Biotechnology 36
Countries citing papers authored by Yi Ba
This map shows the geographic impact of Yi Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ba more than expected).
Fields of papers citing papers by Yi Ba
This network shows the impact of papers produced by Yi Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ba. The network helps show where Yi Ba may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 132 | |
| 2 | 2018 | 103 | |
| 3 | 2007 | 87 | |
| 4 | 2021 | 86 | |
| 5 | 2021 | 51 | |
| 6 | 2019 | 46 | |
| 7 | 2018 | 45 | |
| 8 | 2017 | 34 | |
| 9 | 2017 | 26 | |
| 10 | 2013 | 15 | |
| 11 | 2019 | 12 | |
| 12 | 2021 | 10 | |
| 13 | 2024 | 6 | |
| 14 | 2011 | 4 | |
| 15 | Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer | 2020 | 2 |
| 16 | 2024 | 2 | |
| 17 | MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する | 2001 | 1 |
| 18 | 2024 | 1 | |
| 19 | [Down-regulative expression of microRNAs cluster in human colon tumorigenesis]. | 2008 | 1 |
| 20 | 2021 | 1 |
About Yi Ba
Yi Ba is a scholar working on Molecular Biology, Cancer Research, Surgery, Materials Chemistry and Oncology, having authored 23 papers that have together received 665 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers), Extracellular vesicles in disease (5 papers), Shape Memory Alloy Transformations (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), RNA Interference and Gene Delivery (2 papers) and High Entropy Alloys Studies (2 papers). The work is most often cited by research in Cancer Research (322 citations), Molecular Biology (503 citations), Immunology (119 citations), Geriatrics and Gerontology (18 citations) and Biotechnology (36 citations). Yi Ba has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Haiyang Zhang, Ting Deng, Xinyi Wang, Guoguang Ying, Ralph A. Reisfeld, Noriko Mizutani, Yunping Luo, Rong Xiang, Masato Mizutani and Juergen C. Becker. Their work appears in journals such as Cancer Research, Molecular Oncology, Investigational New Drugs, Cell Research and Cold Spring Harbor Perspectives in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.